Abbott Laboratories
ABT
$105.90
Share price
-0.02%
Change (1 day)
-5.24%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Market capitalization of Abbott Laboratories (ABT)
Market cap: $183.75 Billion
As of May 2024 Abbott Laboratories has a market cap of $183.75 Billion. This makes Abbott Laboratories the world's 67th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Abbott Laboratories from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $183.75 B | -3.84% |
| 2023 | $191.08 B | -0.18% |
| 2022 | $191.42 B | -23.08% |
| 2021 | $248.86 B | 28.25% |
| 2020 | $194.05 B | 26.76% |
| 2019 | $153.09 B | 20.56% |
| 2018 | $126.98 B | 27.83% |
| 2017 | $99.33 B | 75.66% |
| 2016 | $56.55 B | -14.49% |
| 2015 | $66.13 B | -2.58% |
| 2014 | $67.89 B | 14.41% |
| 2013 | $59.33 B | -42.54% |
| 2012 | $103.27 B | 17.9% |
| 2011 | $87.59 B | 18.19% |
| 2010 | $74.11 B | -11.5% |
| 2009 | $83.74 B | 1.13% |
| 2008 | $82.80 B | -4.85% |
| 2007 | $87.02 B | 16.22% |
| 2006 | $74.87 B | 23.38% |
| 2005 | $60.69 B | -16.6% |
| 2004 | $72.77 B | -0.64% |
| 2003 | $73.24 B | 16.6% |
| 2002 | $62.81 B | -27.86% |
| 2001 | $87.07 B |
End of Day market cap according to different sources
On May 3rd, 2024 the market cap of Abbott Laboratories was reported to be:
$183.75 Billion
$183.75 Billion
$183.75 Billion
$183.72 Billion
$183.79 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $359.24 B | 95.50% | 🇺🇸 USA |
 Novartis NVS | $198.47 B | 8.01% | 🇨🇭 Switzerland |
 Pfizer PFE | $157.47 B | -14.30% | 🇺🇸 USA |
 Medtronic MDT | $108.46 B | -40.97% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $218.48 B | 18.90% | 🇺🇸 USA |
 Boston Scientific BSX | $107.10 B | -41.71% | 🇺🇸 USA |
 Hologic HOLX | $17.96 B | -90.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $89.17 B | -51.47% | 🇺🇸 USA |
 AstraZeneca AZN | $237.33 B | 29.16% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $88.69 B | -51.73% | 🇬🇧 UK |